Abstract
Metabotropic glutamate receptor 7 (mGluR7) remains the most elusive of the eight known mGluRs primarily because of the limited availability of tool compounds to interrogate its potential therapeutic utility. The discovery of N,N′-dibenzhydrylethane-1,2-diamine dihydrochloride (AMN082) as the first orally active, brain-penetrable, mGluR7-selective allosteric agonist by Mitsukawa and colleagues (Proc Natl Acad Sci USA 102:18712–18717, 2005) provides a means to investigate this receptor system directly. AMN082 demonstrates mGluR7 agonist activity in vitro and interestingly has a behavioral profile that supports utility across a broad spectrum of psychiatric disorders including anxiety and depression. The present studies were conducted to extend the in vitro and in vivo characterization of AMN082 by evaluating its pharmacokinetic and metabolite profile. Profiling of AMN082 in rat liver microsomes revealed rapid metabolism (t1/2 < 1 min) to a major metabolite, N-benzhydrylethane-1,2-diamine (Met-1). In vitro selectivity profiling of Met-1 demonstrated physiologically relevant transporter binding affinity at serotonin transporter (SERT), dopamine transporter (DAT), and norepinephrine transporter (NET) (323, 3020, and 3410 nM, respectively); whereas the parent compound AMN082 had appreciable affinity at NET (1385 nM). AMN082 produced antidepressant-like activity and receptor occupancy at SERT up to 4 h postdose, a time point at which AMN082 is significantly reduced in brain and plasma while the concentration of Met-1 continues to increase in brain. Acute Met-1 administration produced antidepressant-like activity as would be expected from its in vitro profile as a mixed SERT, NET, DAT inhibitor. Taken together, these data suggest that the reported in vivo actions of AMN082 should be interpreted with caution, because they may involve other mechanisms in addition to mGluR7.
Footnotes
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
doi:10.1124/jpet.110.177378.
-
ABBREVIATIONS:
- mGlu
- metabotropic glutamate
- mGluR
- mGlu receptor
- CNS
- central nervous system
- AMN082
- N,N′-dibenzhydrylethane-1,2-diamine dihydrochloride
- Met-1
- metabolite 1 (N-benzhydrylethane-1,2-diamine)
- AUC0-t
- area under the curve at last observed time point
- tmax
- time at maximum concentration
- Cmax
- maximum concentration
- LC
- liquid chromatography
- HPLC
- high-performance LC
- MS
- mass spectrometry
- SERT
- serotonin transporter
- NET
- norepinephrine transporter
- DAT
- dopamine transporter
- DASB
- N,N-dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine
- SSRI
- selective serotonin reuptake inhibitor
- ANOVA
- analysis of variance
- KO
- knockout
- ACN
- acetonitrile
- RLM
- rat liver microsomes
- CHO
- Chinese hamster ovary
- WIN 35428
- 2β-carbomethoxy-3β-(4-fluorophenyl)tropane
- L-AP4
- (2S)-2-amino-4-phosphonobutanoic acid
- ESI
- electrospray ionization
- i.p.
- intraperitoneally
- 5-HT
- 5-hydroxytryptamine.
- Received November 21, 2010.
- Accepted April 12, 2011.
- Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|